|
Real Estate News Releases
|
(EMAILWIRE.COM, February 26, 2011 ) Boston, MA - InsiderCow.com: NOVARTIS PHARMA AG, other 10% owner of IDENIX PHARMACEUTICALS INC (NasdaqGM: IDIX) bought 20,993 shares of IDIX from the open market on 2011-02-25 according to an SEC filing reported by insidercow.com at 2011-02-25 10:49:18 ET. The stock was up 4.85% after the InsiderCow.com report.
Trade amount: 20,993 Shares
Trade type: Open Market Buy
Price Range: $2.41-$5.11
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=IDIX You can also get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.
About InsiderCow.com
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
About IDIX:
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases in the United States and Europe.
Disclosure: Insidercow.com is not a registered investment advisers or broker/dealer. Insidercow.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.
CONTACT: InsiderCow.com
e-mail: support@insidercow.com
WWW: http://www.insidercow.com
InsiderCow
Kevin Leng
781-526-8657
support@insidercow.com
|
|
|
Real Estate News by Sector
|
|
|
|